List of works - Jennifer A Westwood

Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice

scientific article

Adoptive transfer of T cells modified with a humanized chimeric receptor gene inhibits growth of Lewis-Y-expressing tumors in mice

scholarly article

Chimeric antigen receptor-redirected T cells display multifunctional capacity and enhanced tumor-specific cytokine secretion upon secondary ligation of chimeric receptor

scientific article published in June 2013

Combination anti-CD137 and anti-CD40 antibody therapy in murine myc-driven hematological cancers.

scientific article published on 2 June 2014

Combined natural killer T-cell based immunotherapy eradicates established tumors in mice

scientific article published on August 2007

Cross-talk between tumors can affect responses to therapy

scientific article published on 17 June 2015

Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway

scientific article published on January 2004

Differential potency of regulatory T cell-mediated immunosuppression in kidney tumors compared to subcutaneous tumors

scientific article

Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting.

scientific article published on 13 December 2016

Engineering T cell function using chimeric antigen receptors identified using a DNA library approach

scientific article

Enhancing adoptive immunotherapy of cancer.

scientific article published on April 2010

Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment

scientific article published on 2 August 2013

Environmental enrichment does not impact on tumor growth in mice.

scientific article published on 12 June 2013

Erratum to: Psychological distress, quality of life, symptoms and unmet needs of colorectal cancer survivors near the end of treatment

scientific article published on 01 September 2015

Expression of a Chimeric Antigen Receptor in Multiple Leukocyte Lineages in Transgenic Mice

scientific article

Foxp3 expression in macrophages associated with RENCA tumors in mice.

scientific article

Gene modification strategies to induce tumor immunity.

scientific article

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

scientific article

Interleukin 21 enhances antibody-mediated tumor rejection

scientific article

Mobile Health Intervention to Increase Oral Cancer Therapy Adherence in Patients With Chronic Myeloid Leukemia (The REMIND System): Clinical Feasibility and Acceptability Assessment.

scientific article published on 6 December 2017

Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia

scientific article published on 08 July 2013

Psychological distress, quality of life, symptoms and unmet needs of colorectal cancer survivors near the end of treatment.

scientific article published on 9 January 2015

Routes of delivery for CpG and anti-CD137 for the treatment of orthotopic kidney tumors in mice

scientific article

Sustained antigen-specific antitumor recall response mediated by gene-modified CD4+ T helper-1 and CD8+ T cells

scientific article published in December 2007

The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serum

scientific article

The potential impact of mouse model selection in preclinical evaluation of cancer immunotherapy

scientific article published on 3 July 2014

Three agonist antibodies in combination with high-dose IL-2 eradicate orthotopic kidney cancer in mice

scientific article

Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy

scientific article published on 19 September 2013

Toll-Like Receptor Triggering and T-Cell Costimulation Induce Potent Antitumor Immunity in Mice

scientific article published in December 2009

Tumor ablation by gene-modified T cells in the absence of autoimmunity.

scientific article published on 23 November 2010

List of works by Jennifer A Westwood

Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice

Adoptive transfer of T cells modified with a humanized chimeric receptor gene inhibits growth of Lewis-Y-expressing tumors in mice

Chimeric antigen receptor-redirected T cells display multifunctional capacity and enhanced tumor-specific cytokine secretion upon secondary ligation of chimeric receptor

Combination anti-CD137 and anti-CD40 antibody therapy in murine myc-driven hematological cancers.

Combined natural killer T-cell based immunotherapy eradicates established tumors in mice

Cross-talk between tumors can affect responses to therapy

Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway

Differential potency of regulatory T cell-mediated immunosuppression in kidney tumors compared to subcutaneous tumors

Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting.

Engineering T cell function using chimeric antigen receptors identified using a DNA library approach

Enhancing adoptive immunotherapy of cancer.

Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment

Environmental enrichment does not impact on tumor growth in mice.

Erratum to: Psychological distress, quality of life, symptoms and unmet needs of colorectal cancer survivors near the end of treatment

Expression of a Chimeric Antigen Receptor in Multiple Leukocyte Lineages in Transgenic Mice

Foxp3 expression in macrophages associated with RENCA tumors in mice.

Gene modification strategies to induce tumor immunity.

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

Interleukin 21 enhances antibody-mediated tumor rejection

Mobile Health Intervention to Increase Oral Cancer Therapy Adherence in Patients With Chronic Myeloid Leukemia (The REMIND System): Clinical Feasibility and Acceptability Assessment.

Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia

Psychological distress, quality of life, symptoms and unmet needs of colorectal cancer survivors near the end of treatment.

Routes of delivery for CpG and anti-CD137 for the treatment of orthotopic kidney tumors in mice

Sustained antigen-specific antitumor recall response mediated by gene-modified CD4+ T helper-1 and CD8+ T cells

The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serum

The potential impact of mouse model selection in preclinical evaluation of cancer immunotherapy

Three agonist antibodies in combination with high-dose IL-2 eradicate orthotopic kidney cancer in mice

Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy

Toll-Like Receptor Triggering and T-Cell Costimulation Induce Potent Antitumor Immunity in Mice

Tumor ablation by gene-modified T cells in the absence of autoimmunity.